Assessing Hospital Pharmacists' Scope of Clinical Practice in Ontario.

Sarah Tessier, Victor Tsang, Spencer Martin
{"title":"Assessing Hospital Pharmacists' Scope of Clinical Practice in Ontario.","authors":"Sarah Tessier, Victor Tsang, Spencer Martin","doi":"10.4212/cjhp.3491","DOIUrl":null,"url":null,"abstract":"Background\nExpansion of the scope of pharmacists' activities in hospital is associated with reductions in adverse events and drug-related readmissions. However, the breadth of hospital pharmacists' clinical activities varies widely across Ontario due to provisions in the provincial Public Hospitals Act. Few data exist defining expanded scope in institutions across Ontario.\n\n\nObjectives\nThe primary objective was to describe the scope of practice of hospital pharmacists in Ontario who were undertaking expanded clinical activities based on policies or medical directives. The secondary objectives included determining benefits, limitations, facilitators, and barriers associated with implementing these activities.\n\n\nMethods\nA survey was sent to the pharmacy leadership of Groups A and B public hospitals across Ontario. The survey contained quantitative and qualitative questions focused on 3 domains of expanded-scope activities: adaptation, discontinuation, and renewal of medication orders; prescriptive authority; and drug monitoring.\n\n\nResults\nOf 56 hospitals invited, 46 (82%) submitted a survey response, with 1 exclusion (due to no response on some mandatory questions). The most common expanded-scope activity was independent performance of therapeutic drug monitoring (71%, 32/45). Pharmacists had the authority to independently adapt, discontinue, or renew inpatient medication orders in 60% (27/45) of hospitals, and could independently initiate medication orders in 20% (9/45). Barriers to implementing expanded-scope activities included limited time and staffing. Facilitators included proactive leadership, demonstrated clinical value, and strong rapport with other health care providers.\n\n\nConclusions\nMany institutions in Ontario have established polices to expand pharmacists' clinical activities, but there is a great deal of variability in scope of practice. Advocacy at the provincial level to unify scope of practice will help to optimize patient outcomes.","PeriodicalId":94225,"journal":{"name":"The Canadian journal of hospital pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Canadian journal of hospital pharmacy","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.4212/cjhp.3491","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Expansion of the scope of pharmacists' activities in hospital is associated with reductions in adverse events and drug-related readmissions. However, the breadth of hospital pharmacists' clinical activities varies widely across Ontario due to provisions in the provincial Public Hospitals Act. Few data exist defining expanded scope in institutions across Ontario. Objectives The primary objective was to describe the scope of practice of hospital pharmacists in Ontario who were undertaking expanded clinical activities based on policies or medical directives. The secondary objectives included determining benefits, limitations, facilitators, and barriers associated with implementing these activities. Methods A survey was sent to the pharmacy leadership of Groups A and B public hospitals across Ontario. The survey contained quantitative and qualitative questions focused on 3 domains of expanded-scope activities: adaptation, discontinuation, and renewal of medication orders; prescriptive authority; and drug monitoring. Results Of 56 hospitals invited, 46 (82%) submitted a survey response, with 1 exclusion (due to no response on some mandatory questions). The most common expanded-scope activity was independent performance of therapeutic drug monitoring (71%, 32/45). Pharmacists had the authority to independently adapt, discontinue, or renew inpatient medication orders in 60% (27/45) of hospitals, and could independently initiate medication orders in 20% (9/45). Barriers to implementing expanded-scope activities included limited time and staffing. Facilitators included proactive leadership, demonstrated clinical value, and strong rapport with other health care providers. Conclusions Many institutions in Ontario have established polices to expand pharmacists' clinical activities, but there is a great deal of variability in scope of practice. Advocacy at the provincial level to unify scope of practice will help to optimize patient outcomes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估安大略省医院药剂师的临床实践范围。
背景扩大药剂师在医院的活动范围与减少不良事件和与药物相关的再入院率有关。然而,由于省《公立医院法》的规定,安大略省各地医院药剂师临床活动的范围差异很大。首要目标是描述安大略省医院药剂师的执业范围,他们根据政策或医疗指令扩大了临床活动范围。次要目标包括确定与实施这些活动相关的益处、局限性、促进因素和障碍。方法向安大略省 A 组和 B 组公立医院的药剂科领导发送了一份调查问卷。调查包含定量和定性问题,主要集中在扩大范围活动的 3 个领域:用药指令的调整、中止和更新;处方权;以及药物监控。结果 在受邀的 56 家医院中,46 家(82%)提交了调查回复,1 家医院被排除在外(因为对一些必答问题没有回复)。最常见的扩大范围活动是独立开展治疗药物监测(71%,32/45)。在 60% 的医院(27/45)中,药剂师有权独立调整、终止或更新住院患者用药医嘱,在 20% 的医院(9/45)中,药剂师可以独立启动用药医嘱。实施扩大范围活动的障碍包括时间和人员有限。结论安大略省的许多机构都制定了扩大药剂师临床活动范围的政策,但在执业范围方面存在很大差异。在省级层面倡导统一执业范围将有助于优化患者的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Adverse Drug Reactions and Predictors of Medication Adherence in Patients with Prostate Cancer. Changes in Acute Care Pharmacist Prescribing and Laboratory Ordering over Time: CAPLET Study. Continuous IV Deferoxamine for Chronic Iron Overload in Patients Undergoing Hemodialysis by Home Parenteral Therapy: A Case Report and Literature Review. Efficacité de 6 scénarios de décontamination de bras de fauteuils contaminés volontairement au cyclophosphamide. Glycemic Management in Patients with COVID-19 Admitted to the Intensive Care Unit: Evaluation of Glycemic Control and Drug Therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1